Traver RD - Search Results

1

Increased activity and expression of NAD(P)H:quinone acceptor oxidoreductase in confluent cell cultures and within multicellular spheroids.

Phillips RM, de la Cruz A, Traver RD, Gibson NW. Phillips RM, et al. Among authors: traver rd. Cancer Res. 1994 Jul 15;54(14):3766-71. Cancer Res. 1994. PMID: 8033096

2

NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.

Traver RD, Horikoshi T, Danenberg KD, Stadlbauer TH, Danenberg PV, Ross D, Gibson NW. Traver RD, et al. Cancer Res. 1992 Feb 15;52(4):797-802. Cancer Res. 1992. PMID: 1737339

3

Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.

Beall HD, Mulcahy RT, Siegel D, Traver RD, Gibson NW, Ross D. Beall HD, et al. Among authors: traver rd. Cancer Res. 1994 Jun 15;54(12):3196-201. Cancer Res. 1994. PMID: 8205540

4

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D. Traver RD, et al. Br J Cancer. 1997;75(1):69-75. doi: 10.1038/bjc.1997.11. Br J Cancer. 1997. PMID: 9000600 Free PMC article.

5

Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies.

Ross D, Beall H, Traver RD, Siegel D, Phillips RM, Gibson NW. Ross D, et al. Among authors: traver rd. Oncol Res. 1994;6(10-11):493-500. Oncol Res. 1994. PMID: 7620217 Review.

6

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy.

Kelsey KT, Ross D, Traver RD, Christiani DC, Zuo ZF, Spitz MR, Wang M, Xu X, Lee BK, Schwartz BS, Wiencke JK. Kelsey KT, et al. Among authors: traver rd. Br J Cancer. 1997;76(7):852-4. doi: 10.1038/bjc.1997.474. Br J Cancer. 1997. PMID: 9328142 Free PMC article.

7

A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity.

Ross D, Traver RD, Siegel D, Kuehl BL, Misra V, Rauth AM. Ross D, et al. Among authors: traver rd. Br J Cancer. 1996 Sep;74(6):995-6. doi: 10.1038/bjc.1996.477. Br J Cancer. 1996. PMID: 8826876 Free PMC article. No abstract available.

8

Enzymology of bioreductive drug activation.

Ross D, Beall HD, Siegel D, Traver RD, Gustafson DL. Ross D, et al. Among authors: traver rd. Br J Cancer Suppl. 1996 Jul;27:S1-8. Br J Cancer Suppl. 1996. PMID: 8763836 Free PMC article. Review. No abstract available.

9

Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone.

Rothman N, Smith MT, Hayes RB, Traver RD, Hoener B, Campleman S, Li GL, Dosemeci M, Linet M, Zhang L, Xi L, Wacholder S, Lu W, Meyer KB, Titenko-Holland N, Stewart JT, Yin S, Ross D. Rothman N, et al. Among authors: traver rd. Cancer Res. 1997 Jul 15;57(14):2839-42. Cancer Res. 1997. PMID: 9230185

10

Immortalisation of a human diploid fibroblast cell strain: a DT-diaphorase paradox.

Kuehl BL, Brezden CB, Traver RD, Siegel D, Ross D, Renzing J, Rauth AM. Kuehl BL, et al. Among authors: traver rd. Br J Cancer Suppl. 1996 Jul;27:S19-22. Br J Cancer Suppl. 1996. PMID: 8763839 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters